In @jem.org, Steffensen, Bratina, De Zio et al. review emerging strategies to convert immunologically cold tumors into immune-responsive lesions, while highlighting key challenges to clinical translation. rupress.org/jem/article/...
@rupress.org
@rupress.orgIn @jem.org, Steffensen, Bratina, De Zio et al. review emerging strategies to convert immunologically cold tumors into immune-responsive lesions, while highlighting key challenges to clinical translation. rupress.org/jem/article/...
@jem.orgSteffensen, Bratina, De Zio et al. review emerging strategies to convert immunologically cold tumors into immune-responsive lesions, while highlighting key challenges to clinical translation. rupress.org/jem/article/...
@newsen.bsky.socialElephas Biosciences Reveals Groundbreaking Immunotherapy Prediction Data in Cell Reports Medicine #United_States #Immunotherapy #Madison #Elephas_Biosciences #elive_platform
@interestingpatents.bsky.socialHomodimeric chimeric receptors use dimerizing motifs to deliver signals in engineered immune cells for tumor immunotherapy.
Patent application #US20260306631 from #StJudeChildrensResearchHospital #Immunotherapy
@uchicagocancer.bsky.socialA first-of-its-kind clinical trial is testing a new type of personalized cell therapy designed to help the body's own immune system recognize and destroy cancer cells. https://ow.ly/P1m350ZXQU5 #CellTherapy #Immunotherapy #PersonalizedMedicine
@scienceinvancouver.comDr. Poul Sorensen and his team at @bcchresearch.bsky.social are focused on uncovering cellular vulnerabilities and investigating novel #immunotherapy avenues for pediatric cancers.
Check out this Q&A to learn more about the two recent studies from their lab: https://bit.ly/4jFUMJt
@meierlabicr.bsky.socialPleased to share that our recent Phase I clinical trial of tolinapant (ASTX660) combined with pembrolizumab in advanced solid tumours has been selected for the Nature Communications Editors’ Highlights – Cancer collection!
www.nature.com/articles/s41...
#CancerResearch #Immunotherapy
@agentictribune.bsky.socialFDA Expands Use of Anktiva to Treat High-Grade Papillary Non‑Muscle Invasive Bladder Cancer
@imtadvances.bsky.socialPopulation modelling reveals key drivers of CAR T-cell dynamics in lymphoma patients, highlighting roles for lymphodepletion, tumour burden, and cytokines like IL-15/IL-7 🧬
@sigtrans-sttt.bsky.socialHow does tumor metabolism contribute to immune escape?
This review defines metabolic immune checkpoints involving protein modifications, metabolic enzymes, and microbial metabolites as potential #Immunotherapy targets.
#STTT #OpenAccess: doi.org/10.1038/s413...
#Immunometabolism #ImmuneEscape
@newsen.bsky.socialExploring the Future of Personalized Cancer Treatment at Abu Dhabi Health Summit 2026 #Abu_Dhabi #United_Arab_Emirates #Immunotherapy #Precision_Oncology #Likang_Life_Sciences
@bionewscentral.comA new approach can program #NaturalKillerCells inside the body, showing promise for treating diseases linked to dysfunctional #TCells, including #lymphoma and #AutoimmuneHepatitis.
#AutoimmuneDisease #Immunotherapy
@newsramp.comUK researchers may have found a way to stop lung cancer before it starts by clearing 'immune fog' that prevents the immune system from acting early. Cancer interception is gaining momentum as a promising new frontier in oncology. #CancerResearch #Immunotherapy
@asipath.bsky.socialOur final young investigator speaker for 2026 is Dr. Louisa Tichy from @wakeforest.bsky.social! Register now for this #VirtualSeminar https://loom.ly/LColRYk
#ASIPwebinar #pathobiology #ICI #Immunotherapy #Cardiotoxicity
@allermd.bsky.socialReal-world safety and clinical outcomes of #cluster #subcutaneous #immunotherapy with #olive #pollen extracts, with or without #grass pollen, in patients with #allergic #rhinoconjunctivitis and/or #asthma. Open Access. ivancevichmd.blogspo...
@megadoctornews.comFDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer #cancer #CancerTreatment #ColonCancer #DMmr #FdaApproval #immunotherapy #MegaDoctorNews #RioGrandeValley #Stage_3ColonCancer
@coherentcmi.bsky.socialBispecific Antibodies Market: Growth, Trends, and Future Opportunities
Explore the full report from Coherent Market Insights:
www.coherentcmi.com/market-insig...
#BispecificAntibodiesMarket #BispecificAntibodies #Biopharmaceuticals #Immunotherapy #CancerResearch
@amjtransplant.bsky.socialIntroducing our new feature, AJT Catalyst!
buff.ly/HlAxrBr
This month, read "Antibody-cytokine fusion enables spatially targeted modification of immune responses to tumors" by EM Gillis Buck et al
buff.ly/Iq1f7NT
#Immunotherapy #Cytokines #CancerImmunotherapy
@epigenometech.bsky.socialEpigenetics Update - Chromatin accessibility trajectories reveal pre-cancerous epigenetic priming and an acid-driven immunotherapy-resistant gastric cancer subtype www.cell.com/cancer-cell/...
#Epigenetics #Chromatin #Cancer #EpigeneticPriming #Immunotherapy
@imtadvances.bsky.socialA high-affinity ImmTAC® bispecific efficiently redirects T cells to target PRAME+ tumour cells, even at very low antigen levels, highlighting its promise across multiple cancers 🧬
